Räsänen Minna, Carpelan-Holmström Monika, Mustonen Harri, Renkonen-Sinisalo Laura, Lepistö Anna
Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland,
Int J Colorectal Dis. 2015 Jun;30(6):775-85. doi: 10.1007/s00384-015-2182-1. Epub 2015 Mar 22.
After curative rectal cancer surgery, local recurrences manifest in 2.4-10% and distant metastases in 20-50% of patients. The effectiveness of different surveillance regimens is not well established. We evaluated the pattern of recurrence and the utility of different surveillance instruments. Risk factors for recurrence were also recorded.
This retrospective study comprises 580 consecutive rectal cancer patients operated on at Helsinki University Central Hospital, Finland, during 2005-2011. Data were collected from patient records. After exclusions, 481 patients treated with curative intent remained. Patients were followed up according to an intensive surveillance program.
Rectal cancer recurrence was observed in 124 patients (25.8%). Local recurrence manifested in 40 patients (8.3%) and distant metastases in 112 patients (23.3%). Recurrences were observed a median of 1.3 years after surgery. Twelve patients had to be followed up to find one local recurrence and four patients to find one distant metastasis. Recurrences detected during regular follow-up visits were discovered on average earlier than those detected in additional visits arranged because of patient symptoms (p = 0.023 for local recurrence, p = 0.001 for distant metastases). All surveillance instruments were similarly useful in finding recurrence. Curative treatment was possible in 51 (41.1%) of 124 patients with disease recurrence. Follow-up led to a 10.0% chance of detecting recurrence that could be treated with curative intent.
Rectal cancer recurrences are detected earlier within a surveillance program than by symptoms alone. The most intensive follow-up should be focused on patients with known risk factors for recurrence.
在直肠癌根治性手术后,2.4%-10%的患者会出现局部复发,20%-50%的患者会出现远处转移。不同监测方案的有效性尚未明确确立。我们评估了复发模式及不同监测手段的效用。还记录了复发的危险因素。
这项回顾性研究纳入了2005年至2011年期间在芬兰赫尔辛基大学中心医院连续接受手术的580例直肠癌患者。数据从患者记录中收集。排除后,481例接受根治性治疗的患者留存。患者按照强化监测方案进行随访。
124例患者(25.8%)出现直肠癌复发。40例患者(8.3%)出现局部复发,112例患者(23.3%)出现远处转移。复发在术后中位时间1.3年被观察到。发现1例局部复发平均需要随访12例患者,发现1例远处转移平均需要随访4例患者。在定期随访中检测到的复发平均比因患者症状安排的额外随访中检测到的复发更早(局部复发p = 0.023,远处转移p = 0.001)。所有监测手段在发现复发方面同样有用。124例疾病复发患者中有51例(41.1%)可行根治性治疗。随访有10.0%的机会检测到可进行根治性治疗的复发。
在监测方案中比仅通过症状能更早检测到直肠癌复发。最密集的随访应集中于有已知复发危险因素的患者。